AlloVir, Inc. Common Stock

Go to AlloVir, Inc. Common Stock Website

$0.00

(%)
Live
Previous Close

$

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$93.1 million USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

AlloVir Inc is a late clinical-stage cell therapy company. The company focuses on developing innovative allogeneic T-cell therapies to combat viral diseases. Their proprietary VST therapy platform enables the creation of off-the-shelf VSTs, addressin...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Here is how AlloVir, Inc. (ALVR) and Arcutis Biotherapeutics, Inc. (ARQT) have performed compared to their sector so far this year.

Related tickers: ALVR, ARQT.

Read Full Article

The most oversold stocks in the health care presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro. Here’s the latest list of major oversold players in this sector, having an RSI near or below 30. iBio, Inc. (NYSE: IBIO) On Dec. 5, iBio announced pricing of a $4.5 million public offering. The company’s stock fell around 11% ...

Related tickers: GRI, ALVR, IBIO, VYNE.

Read Full Article
Trending Tickers
LASE

XNAS

$0.00
(%)
PACW

XNAS

$0.00
(%)
SMFL

XNAS

$0.00
(%)
SQ

XNYS

$0.00
(%)
MLGO

XNAS

$0.00
(%)